Semaglutide reshapes gut bacteria in obese mice, and fecal transplant transfers these benefits to new hosts | Research

The takeaway

Semaglutide improved obesity, insulin resistance, and hypothalamic appetite genes in HFD mice while reshaping gut microbiota—and fecal microbiota transplantation successfully transferred these metabolic benefits to recipient mice.

FMT transfers semaglutide benefits
Fecal transplant from semaglutide-treated to untreated mice transferred metabolic improvements—proving gut microbiota mediates some GLP-1 drug effects

What the researchers found

Semaglutide: ↓weight, fat, FBG, insulin, HOMA-IR. Modulated liver/adipose metabolic genes + hypothalamic appetite genes. Reshaped gut microbiota. FMT transferred benefits to recipients. Weight rebounded 4 weeks after stopping. Amino acid and pyrimidine metabolism affected.

Why it matters

This proves semaglutide's benefits are partly mediated by gut bacteria—not just appetite suppression. The FMT experiment is particularly significant: it shows the metabolic improvements are transmissible through the microbiome.

How the study worked

C57BL/6J mice: ND, HFD, HFD+semaglutide (100 μg/kg). FMT from semaglutide mice to pseudo-germ-free recipients. Serum metabolomics. 16S rRNA gut microbiota. Gene expression (liver, adipose, hypothalamus).

What this study cannot tell us

Mouse study. FMT from drug-treated mice may not replicate human microbiome effects. Weight rebound after cessation may limit long-term benefit of microbiome changes alone.

How to read the evidence

Comprehensive preclinical study with FMT proof of microbiome mediation. Strong mechanistic evidence.

When this study was published

Published in 2025.

The bigger picture

If gut microbiome changes mediate GLP-1 drug effects, this opens the possibility of developing probiotic or microbiome-based therapies that replicate some benefits without ongoing drug use.

Questions still open

Could targeted probiotics replicate semaglutide's microbiome benefits?
Do human GLP-1 drug users show similar microbiome changes?
Would maintaining microbiome changes prevent weight rebound?

Common questions

Does semaglutide change gut bacteria?

Yes. This study showed semaglutide significantly reshaped the gut microbiome in obese mice. More remarkably, when fecal bacteria from semaglutide-treated mice were transplanted to untreated mice, the recipients also gained metabolic benefits—proving the gut bacteria themselves mediate some of the drug's effects.

Could probiotics replace semaglutide?

Not likely as a complete replacement, but this study suggests gut bacteria contribute to semaglutide's benefits. Future research might identify specific bacterial strains that could be used as supplements to enhance or partly replicate GLP-1 drug effects, potentially reducing the need for high drug doses.

Read the original research

Effects of semaglutide on metabolism and gut microbiota in high-fat diet-induced obese mice.

Frontiers in pharmacology, 16, 1562896

View on PubMed ↗Publisher’s paper ↗

Citation

Sun, Luyan; Shang, Bingqing; Lv, Suyuan; Liu, Guolong; Wu, Qiu; Geng, Yue. (2025). Effects of semaglutide on metabolism and gut microbiota in high-fat diet-induced obese mice.. Frontiers in pharmacology, 16, 1562896. https://doi.org/10.3389/fphar.2025.1562896